Lyme Disease Diagnostic Basics

Lyme disease is a bacterial infection caused by the Borrelia burgdorferi bacterium. It is transmitted to humans through the bites of infected blacklegged ticks. The most common symptoms of Lyme disease include fever, headache, fatigue, and a characteristic skin rash called erythema migrans. If left untreated, the infection can spread to joints, the heart, and the nervous system. Lyme disease is difficult to diagnose clinically in its early stages. Laboratory testing is necessary to confirm suspected cases.

Challenges in Early Lyme Disease Diagnostic

One of the major challenges in Lyme Disease Diagnostics early Lyme disease is that the characteristic bull's-eye rash occurs in only about 70–80% of infected individuals. Its appearance can also be unclear or atypical, adding to the difficulty of clinical diagnosis. The non-specific flu-like symptoms such as fever, chills, and muscle aches that accompany early localized infection can easily be mistaken for other illnesses. Additionally, current two-tier serological testing which involves enzyme immunoassay (EIA) and Western Blot analysis has limitations. It may not detect antibodies until several weeks after infection. This means testing may give false negative results when performed too early. Serological tests also cannot distinguish between past and present infections. Together, these factors often lead to delays in diagnosis and appropriate treatment.

Advances in Early Lyme Disease Diagnostic Tests

New diagnostic methods aim to address issues with early diagnosis. Culturing the bacteria from infected skin, blood, or spinal fluid is considered the gold standard but requires specialized laboratories and is rarely done in practice due to difficulties growing B. burgdorferi in culture. Polymerase chain reaction (PCR) tests directly detect the organism's DNA and have a faster turnaround time of 1-2 days compared to serology. However, PCR on blood is only about 50% sensitive during early localized infection. PCR performed on skin biopsies of erythema migrans lesions has a sensitivity of about 70-80% and is being used more often clinically. Other nucleic acid amplification tests that are antibody-independent and more convenient than PCR are also under investigation.

Get More Insights on- Lyme Disease Diagnostics